Harvard University has sued the Trump administration a second time since the start of the ongoing feud between the university and White House.
A three-judge federal appeals court has lifted a lower court order that blocked the federal government from enacting President Trump’s executive order to end collective bargaining by workers at more than a dozen federal agencies.
Legislation aimed at increasing access to breast and cervical cancer screening was introduced May 22 in the U.S. Senate. The bipartisan Screening for Communities to Receive Early and Equitable Needed Services, or SCREENS, for Cancer Act would reauthorize the National Breast and Cervical Cancer Early Detection Program, or NBCCEDP, for fiscal years 2026 through 2030.
Before two consecutive congressional hearings on the Trump administration’s “skinny budget” proposal on May 14, Sen. Bernie Sanders (I-VT), ranking member of the Senate Health, Education, Labor, and Pensions Committee, released a report assessing the administration’s impact on biomedical research.
On May 12, President Trump signed an executive order directing the administration to communicate most-favored-nation drug price targets to pharmaceutical manufacturers for sales in the United States.
The Association of American Cancer Institutes started a monthly newsletter roundup titled “Defending Cancer Research Digest.”
The House Committee on Energy and Commerce budget reconciliation bill, which includes attacks on Medicaid and Affordable Care Act coverage and fails to extend ACA tax credits, would increase the number of uninsured people by at least 13.7 million.
The Kaiser Family Foundation has released a tracking poll compiling data from the first 100 days of the Trump administration.
Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts
Harvard University filed an amended lawsuit against the Trump administration, seeking to add two more federal agencies as defendants and to address the administration’s widening efforts to cut the university’s federal funding—now targeting over $2.6 billion and all future grants.
Over $180 million in NCI grants have been terminated between Feb. 28 and April 8, according to a systematic review published in JAMA May 8.
